価格表

在庫・価格 : 2024年05月18日 09時12分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-Human Survivin Affinity Purified Polyclonal Ab
データシート※最新のデータシートでない場合があります
AF886-SP RSDアールアンドディー システムス
R&D Systems, Inc.
25 μg ¥30,000
(未発注)
追加

在庫・価格 : 2024年05月18日 09時12分 現在

Anti-Human Survivin Affinity Purified Polyclonal Ab

  • 商品コード:AF886-SP
  • メーカー:RSD
  • 包装:25μg
  • 価格: ¥30,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Jiang X et al. Disruption of Wnt/&#x3B2;-Catenin Exerts Antileukemia Activity and Synergizes with FLT3 Inhibition in <i>FLT3</i>-Mutant Acute Myeloid Leukemia. Clin Cancer Res 2018 05;24(10):2417-2429
Jiang X et al
2018/01/01
Species: Human, Applications: Western Blot PubMed
2 Lin TY et al. BIRC5/Survivin is a novel ATG12-ATG5 conjugate interactor and an autophagy-induced DNA damage suppressor in human cancer and mouse embryonic fibroblast cells. Autophagy 2020 Jul;16(7):1296-1313
Lin TY et al
2020/01/01
Species: Human, Applications: Western Blot PubMed
3 Garrido MP et al. NGF-Enhanced Vasculogenic Properties of Epithelial Ovarian Cancer Cells Is Reduced by Inhibition of the COX-2/PGE<sub>2</sub> Signaling Axis. Cancers (Basel) 2019 Dec;11(12)
Garrido MP et al
2019/01/01
Species: Human, Applications: Western Blot PubMed
4 Nishisaka F et al. Antitumor activity of a novel oral signal transducer and activator of transcription 3 inhibitor YHO-1701. Cancer Sci 2020 May;111(5):1774-1784
Nishisaka F et al
2020/01/01
Species: Human, Applications: Western Blot PubMed
5 Jugel W et al. Targeted RNAi of BIRC5/Survivin Using Antibody-Conjugated Poly(Propylene Imine)-Based Polyplexes Inhibits Growth of PSCA-Positive Tumors. Pharmaceutics 2021 May;13(5)
Jugel W et al
2021/01/01
Species: Human, Applications: Western Blot PubMed
6 Rodrigues Moita AJ et al. Priming with HDAC Inhibitors Sensitizes Ovarian Cancer Cells to Treatment with Cisplatin and HSP90 Inhibitors. Int J Mol Sci 2020 Nov;21(21)
Rodrigues Moita AJ et al
2020/01/01
Species: Human, Applications: Western Blot PubMed
  • No.: 1
  • 文献情報:
    Jiang X et al. Disruption of Wnt/&#x3B2;-Catenin Exerts Antileukemia Activity and Synergizes with FLT3 Inhibition in <i>FLT3</i>-Mutant Acute Myeloid Leukemia. Clin Cancer Res 2018 05;24(10):2417-2429
    Jiang X et al
    2018/01/01
  • 備考:
    Species: Human, Applications: Western Blot
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Lin TY et al. BIRC5/Survivin is a novel ATG12-ATG5 conjugate interactor and an autophagy-induced DNA damage suppressor in human cancer and mouse embryonic fibroblast cells. Autophagy 2020 Jul;16(7):1296-1313
    Lin TY et al
    2020/01/01
  • 備考:
    Species: Human, Applications: Western Blot
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Garrido MP et al. NGF-Enhanced Vasculogenic Properties of Epithelial Ovarian Cancer Cells Is Reduced by Inhibition of the COX-2/PGE<sub>2</sub> Signaling Axis. Cancers (Basel) 2019 Dec;11(12)
    Garrido MP et al
    2019/01/01
  • 備考:
    Species: Human, Applications: Western Blot
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Nishisaka F et al. Antitumor activity of a novel oral signal transducer and activator of transcription 3 inhibitor YHO-1701. Cancer Sci 2020 May;111(5):1774-1784
    Nishisaka F et al
    2020/01/01
  • 備考:
    Species: Human, Applications: Western Blot
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Jugel W et al. Targeted RNAi of BIRC5/Survivin Using Antibody-Conjugated Poly(Propylene Imine)-Based Polyplexes Inhibits Growth of PSCA-Positive Tumors. Pharmaceutics 2021 May;13(5)
    Jugel W et al
    2021/01/01
  • 備考:
    Species: Human, Applications: Western Blot
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Rodrigues Moita AJ et al. Priming with HDAC Inhibitors Sensitizes Ovarian Cancer Cells to Treatment with Cisplatin and HSP90 Inhibitors. Int J Mol Sci 2020 Nov;21(21)
    Rodrigues Moita AJ et al
    2020/01/01
  • 備考:
    Species: Human, Applications: Western Blot
  • 参照:
    PubMed